相似文献
1
Starting Antihypertensive Drug Treatment With Combination Therapy: Controversies in Hypertension - Con Side of the Argument.
Hypertension. 2021 Mar 3;77(3):788-798. doi: 10.1161/HYPERTENSIONAHA.120.12858. Epub 2021 Feb 10.
2
Starting Antihypertensive Drug Treatment With Combination Therapy: Controversies in Hypertension - Pro Side of the Argument.
Hypertension. 2021 Mar 3;77(3):800-805. doi: 10.1161/HYPERTENSIONAHA.120.12857. Epub 2021 Feb 10.
3
Roundtable Discussion: Blood pressure lowering by any means, or do specific medications make a difference?
J Clin Hypertens (Greenwich). 2001 Nov-Dec;3(6):369-75. doi: 10.1111/j.1524-6175.2001.00494.x.
4
Trends in antihypertensive treatment--lessons from the National Acute Stroke Israeli (NASIS) registry.
Blood Press. 2014 Oct;23(5):262-9. doi: 10.3109/08037051.2013.876771. Epub 2014 Feb 3.
5
Pressor responses to antihypertensive drug types.
Am J Hypertens. 2010 Sep;23(9):1031-7. doi: 10.1038/ajh.2010.114. Epub 2010 Aug 19.
6
Is it time for a new approach to the initial treatment of hypertension?
Arch Intern Med. 2001 May 14;161(9):1140-4. doi: 10.1001/archinte.161.9.1140.
7
Combination therapy for hypertension.
Nat Rev Cardiol. 2009 Apr;6(4):270-1. doi: 10.1038/nrcardio.2009.31.
8
[Combined antihypertensive therapy: review of multicenter studies conducted in foreign countries].
Ter Arkh. 1999;71(8):74-8.
9
Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension.
Hypertens Res. 2014 Jun;37(6):585-90. doi: 10.1038/hr.2014.33. Epub 2014 Mar 27.
10
The ABCD of anti-hypertensive therapy?
J Hypertens. 2002 Apr;20(4):615-6. doi: 10.1097/00004872-200204000-00016.
引用本文的文献
1
Renal Safety of Telminuvo, a Single Pill Combination of Telmisartan and S-amlodipine, in Korean Hypertensive Patients: A Multicenter, Retrospective Cohort Study.
Electrolyte Blood Press. 2025 Jun;23(1):1-10. doi: 10.5049/EBP.2025.23.e1. Epub 2025 May 8.
2
Pharmacotherapy for obesity: are we ready to select, tailor and combine pharmacotherapy to achieve more ambitious goals?
Front Endocrinol (Lausanne). 2025 Jun 18;16:1569468. doi: 10.3389/fendo.2025.1569468. eCollection 2025.
3
Molecular mechanisms and intervention approaches of heart failure (Review).
Int J Mol Med. 2025 Aug;56(2). doi: 10.3892/ijmm.2025.5566. Epub 2025 Jun 13.
4
Cardiovascular Effects of Herbal Products and Their Interaction with Antihypertensive Drugs-Comprehensive Review.
Int J Mol Sci. 2024 Jun 9;25(12):6388. doi: 10.3390/ijms25126388.
5
Prevalence of hypertension in Iran: An updated systematic review and meta-analysis of community-based studies.
Caspian J Intern Med. 2023 Fall;14(4):607-617. doi: 10.22088/cjim.14.43.607.
6
Polypill and Combination Therapy: Blood Pressure and Cardiovascular Risk Reduction.
Curr Cardiol Rep. 2023 Dec;25(12):1851-1858. doi: 10.1007/s11886-023-02000-7. Epub 2023 Nov 22.
7
Improved Persistence to Medication, Decreased Cardiovascular Events and Reduced All-Cause Mortality in Hypertensive Patients With Use of Single-Pill Combinations: Results From the START-Study.
Hypertension. 2023 May;80(5):1127-1135. doi: 10.1161/HYPERTENSIONAHA.122.20810. Epub 2023 Mar 29.
8
[Cardiovascular preventive recommendations. PAPPS 2022 thematic updates. Working groups of the PAPPS].
Aten Primaria. 2022 Oct;54 Suppl 1(Suppl 1):102444. doi: 10.1016/j.aprim.2022.102444.
9
DPP3: From biomarker to therapeutic target of cardiovascular diseases.
Front Cardiovasc Med. 2022 Oct 12;9:974035. doi: 10.3389/fcvm.2022.974035. eCollection 2022.
10
Comparison between the world health organization (WHO) and international society of hypertension (ISH) guidelines for hypertension.
Ann Med. 2022 Dec;54(1):837-845. doi: 10.1080/07853890.2022.2044510.
本文引用的文献
1
Heterogeneous Patient Preferences for Modern Antiretroviral Therapy: Results of a Discrete Choice Experiment.
Value Health. 2020 Jul;23(7):851-861. doi: 10.1016/j.jval.2020.03.007. Epub 2020 Jul 18.
2
2020 International Society of Hypertension Global Hypertension Practice Guidelines.
Hypertension. 2020 Jun;75(6):1334-1357. doi: 10.1161/HYPERTENSIONAHA.120.15026. Epub 2020 May 6.
3
Medication adherence in hypertension.
J Hypertens. 2020 Apr;38(4):579-587. doi: 10.1097/HJH.0000000000002294.
4
Economic evaluation of olmesartan/amlodipine fixed-dose combination for hypertension treatment in China.
J Med Econ. 2020 Apr;23(4):394-400. doi: 10.1080/13696998.2019.1699799. Epub 2020 Jan 25.
5
The uses and expenses of antihypertensive medications among hypertensive adults.
Res Social Adm Pharm. 2020 Feb;16(2):183-189. doi: 10.1016/j.sapharm.2019.05.002. Epub 2019 May 8.
6
2018 ESC/ESH Guidelines for the management of arterial hypertension.
Eur Heart J. 2018 Sep 1;39(33):3021-3104. doi: 10.1093/eurheartj/ehy339.
7
Diagnosis and management of resistant hypertension: state of the art.
Nat Rev Nephrol. 2018 Jul;14(7):428-441. doi: 10.1038/s41581-018-0006-6.
8
What is in your wallet? A cluster randomized trial of the effects of showing comparative patient out-of-pocket costs on primary care prescribing for uncomplicated hypertension.
Implement Sci. 2018 Jan 10;13(1):7. doi: 10.1186/s13012-017-0701-x.
9
Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double-Blind Randomized Controlled Trial.
J Am Heart Assoc. 2017 Nov 18;6(11):e006986. doi: 10.1161/JAHA.117.006986.
10
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
J Am Coll Cardiol. 2018 May 15;71(19):e127-e248. doi: 10.1016/j.jacc.2017.11.006. Epub 2017 Nov 13.
Zotero 插件
